HWG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,994
Closed -$1.83M 54
2026
Q1
$1.83M Buy
+1,994
New +$2.02M 0.48% 35
2025
Q2
Sell
-243
Closed -$201K 97
2025
Q1
$201K Buy
+243
New +$202K 0.09% 41
2024
Q4
Sell
-6,125
Closed -$5.43M 53
2024
Q3
$5.43M Sell
6,125
-10,334
-63% -$9.29M 1.87% 16
2024
Q2
$14.9M Buy
+16,459
New +$13.2M 5.46% 4
2023
Q4
$2.72M Buy
4,665
+174
+4% +$102K 1.22% 22
2023
Q3
$2.41M Buy
4,491
+3,900
+660% +$2.01M 1.31% 14
2023
Q2
$277K Buy
+591
New +$248K 0.13% 53
2022
Q1
Sell
-102
Closed -$28K 162
2021
Q4
$28K Buy
+102
New +$25.9K 0.01% 90
2021
Q1
Sell
-389
Closed -$66K 115
2020
Q4
$66K Sell
389
-1,415
-78% -$211K 0.03% 75
2020
Q3
$267K Sell
1,804
-844
-32% -$131K 0.24% 57
2020
Q2
$435K Buy
+2,648
New +$406K 0.35% 44
2019
Q4
$10K Buy
+74
New +$8.58K 0.01% 104

Other funds holding LLY

HWG Holdings's LLY Position: Q2 2026 in Review

HWG Holdings sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,994 shares — an estimated $1.83M sold.

HWG Holdings first reported a position in LLY in Q4 2019 and held it in 12 quarters. The position peaked at $14.9M in Q2 2024. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HWG Holdings reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • HWG Holdings sold 1,994 Eli Lilly shares in Q2 2026, an estimated $1.83M.
  • HWG Holdings first reported a position in Eli Lilly in Q4 2019 and held it in 12 quarters.
  • HWG Holdings's Eli Lilly position peaked at $14.9M in Q2 2024.
  • 2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HWG Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.